FDA 483 - GenTrac, Inc. - July 30, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
GenTrac, Inc., a drug substance manufacturer in Middleton, WI, was cited for four observations during an FDA inspection. The findings include uncharacterized residues on equipment surfaces, inadequate microbiological recovery studies for cleaning validation, deficiencies in laboratory training and data management, and a lack of segregation of duties within the Quality Unit. These issues collectively indicate significant concerns regarding quality control, data integrity, and personnel training.
ID · 8f80b7fb-ed45-48c5-9adb-a86ea8d9c8f1